Bayer Aktiengesellschaft (ETR:BAYN) Trading Down 1.5% - Time to Sell?

Key Points

• Bayer Aktiengesellschaft's stock dropped by 1.5%, with shares trading at €27.44 ($31.90) after a mid-day low of €27.26 ($31.69).
• The company's market capitalization stands at $27.70 billion, and it has a P/E ratio of -31.47.
• Bayer operates in various segments including Pharmaceuticals, Consumer Health, and Crop Science, focusing on innovative therapeutic products and solutions.

Shares of Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) traded down 1.5% during trading on Wednesday . The company traded as low as €27.26 ($32.06) and last traded at €27.44 ($32.28). 1,849,640 shares traded hands during trading, The stock had previously closed at €27.86 ($32.78).

Bayer Aktiengesellschaft Stock Down 1.5%

The business's 50-day moving average price is €27.43 and its 200-day moving average price is €24.91. The firm has a market capitalization of $28.42 billion, a PE ratio of -32.30, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.